Literature DB >> 33407653

miR-142 downregulation alleviates rat PTSD-like behaviors, reduces the level of inflammatory cytokine expression and apoptosis in hippocampus, and upregulates the expression of fragile X mental retardation protein.

Peng-Yin Nie1, Lei Tong1, Ming-Da Li2, Chang-Hai Fu1, Jun-Bo Peng1, Li-Li Ji3.   

Abstract

BACKGROUND: FMRP is a selective mRNA-binding protein that regulates protein synthesis at synapses, and its loss may lead to the impairment of trace fear memory. Previously, we found that FMRP levels in the hippocampus of rats with post-traumatic stress disorder (PTSD) were decreased. However, the mechanism underlying these changes remains unclear.
METHODS: Forty-eight male Sprague-Dawley rats were randomly divided into four groups. The experimental groups were treated with the single-prolonged stress (SPS) procedure and injected with a lentivirus-mediated inhibitor of miR-142-5p. Behavior test as well as morphology and molecular biology experiments were performed to detect the effect of miR-142 downregulation on PTSD, which was further verified by in vitro experiments.
RESULTS: We found that silence of miRNA-142 (miR-142), an upstream regulator of FMRP, could alleviate PTSD-like behaviors of rats exposed to the SPS paradigm. MiR-142 silence not only decreased the levels of proinflammatory mediators, such as interleukin-1β, interleukin-6, and tumor necrosis factor-α, but also increased the expressive levels of synaptic proteins including PSD95 and synapsin I in the hippocampus, which was one of the key brain regions associated with PTSD. We further detected that miR-142 silence also downregulated the transportation of nuclear factor kappa-B (NF-κB) into the nuclei of neurons and might further affect the morphology of neurons.
CONCLUSIONS: The results revealed miR-142 downregulation could alleviate PTSD-like behaviors through attenuating neuroinflammation in the hippocampus of SPS rats by binding to FMRP.

Entities:  

Keywords:  FMRP; Inflammation; NF-κB; Post-traumatic stress disorder; miR-142

Year:  2021        PMID: 33407653     DOI: 10.1186/s12974-020-02064-0

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  50 in total

Review 1.  Diagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience Research.

Authors:  Vasiliki Michopoulos; Seth Davin Norrholm; Tanja Jovanovic
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

Review 2.  Inflammation and post-traumatic stress disorder.

Authors:  Hiroaki Hori; Yoshiharu Kim
Journal:  Psychiatry Clin Neurosci       Date:  2019-02-21       Impact factor: 5.188

Review 3.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

4.  Current posttraumatic stress disorder and exaggerated threat sensitivity associated with elevated inflammation in the Mind Your Heart Study.

Authors:  Aoife O'Donovan; Ashkan J Ahmadian; Thomas C Neylan; Mark A Pacult; Donald Edmondson; Beth E Cohen
Journal:  Brain Behav Immun       Date:  2016-10-17       Impact factor: 7.217

5.  Genetic and serum biomarker evidence for a relationship between TNFα and PTSD in Vietnam war combat veterans.

Authors:  Dagmar Bruenig; Divya Mehta; Charles P Morris; Wendy Harvey; Bruce Lawford; Ross McD Young; Joanne Voisey
Journal:  Compr Psychiatry       Date:  2017-01-24       Impact factor: 3.735

Review 6.  The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.

Authors:  Garima Dutta; Ping Zhang; Bin Liu
Journal:  Fundam Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.748

Review 7.  Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression.

Authors:  Ives Cavalcante Passos; Mirela Paiva Vasconcelos-Moreno; Leonardo Gazzi Costa; Maurício Kunz; Elisa Brietzke; João Quevedo; Giovanni Salum; Pedro V Magalhães; Flávio Kapczinski; Márcia Kauer-Sant'Anna
Journal:  Lancet Psychiatry       Date:  2015-11       Impact factor: 27.083

Review 8.  Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond.

Authors:  Vasiliki Michopoulos; Abigail Powers; Charles F Gillespie; Kerry J Ressler; Tanja Jovanovic
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

9.  Posttraumatic stress disorder in the National Comorbidity Survey.

Authors:  R C Kessler; A Sonnega; E Bromet; M Hughes; C B Nelson
Journal:  Arch Gen Psychiatry       Date:  1995-12

10.  Microglial interactions with synapses are modulated by visual experience.

Authors:  Marie-Ève Tremblay; Rebecca L Lowery; Ania K Majewska
Journal:  PLoS Biol       Date:  2010-11-02       Impact factor: 8.029

View more
  4 in total

1.  MicroRNA-124 modulates neuroinflammation in acute methanol poisoning rats via targeting Krüppel-like factor-6.

Authors:  Shu Zhou; Jinjun Li; XiaoNa Zhang; Wen Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Duration of Reduction in Enduring Stress-Induced Hyperalgesia Via FKBP51 Inhibition Depends on Timing of Administration Relative to Traumatic Stress Exposure.

Authors:  Britannia J Wanstrath; Samuel A McLean; Ying Zhao; Jacqueline Mickelson; Michael Bauder; Felix Hausch; Sarah D Linnstaedt
Journal:  J Pain       Date:  2022-03-14       Impact factor: 5.383

3.  Neuroprotective Effect of Acupuncture against Single Prolonged Stress-Induced Memory Impairments and Inflammation in Rat Brain via Modulation of Brain-Derived Neurotrophic Factor Expression.

Authors:  Bombi Lee
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-23       Impact factor: 2.629

4.  The Impact of Electroacupuncture Early Intervention on the Brain Lipidome in a Mouse Model of Post-traumatic Stress Disorder.

Authors:  Cui-Hong Zhou; Fen Xue; Qing-Qing Shi; Shan-Shan Xue; Tian Zhang; Xin-Xu Ma; Li-Sheng Yu; Chuang Liu; Hua-Ning Wang; Zheng-Wu Peng
Journal:  Front Mol Neurosci       Date:  2022-02-10       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.